News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
172,923 Results
Type
Article (8937)
Company Profile (90)
Press Release (163896)
Multimedia
Podcasts (10)
Webinars (6)
Section
Business (51143)
Career Advice (218)
Deals (7590)
Drug Delivery (20)
Drug Development (28245)
Employer Resources (19)
FDA (3174)
Job Trends (4007)
News (88444)
Policy (5912)
Tag
2024 BioCapital Digital (2)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (6)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (4)
2025 Lone Star Bio Digital (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (1)
Academia (519)
Accelerated approval (2)
Adcomms (6)
Allergies (23)
Alliances (14234)
ALS (35)
Alzheimer's disease (356)
Antibody-drug conjugate (ADC) (91)
Approvals (3202)
Artificial intelligence (73)
Autoimmune disease (11)
Automation (3)
Bankruptcy (45)
Best Places to Work (3428)
BIOSECURE Act (14)
Biosimilars (15)
Biotechnology (87)
Bladder cancer (32)
Brain cancer (9)
Breast cancer (142)
Cancer (1181)
Cardiovascular disease (31)
Career advice (205)
Career pathing (4)
CAR-T (71)
Cell therapy (200)
Cervical cancer (7)
Clinical research (22882)
Collaboration (325)
Compensation (122)
Complete response letters (5)
COVID-19 (773)
CRISPR (11)
C-suite (108)
Cystic fibrosis (77)
Data (866)
Depression (11)
Diabetes (57)
Diagnostics (1367)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (58)
Drug pricing (12)
Drug shortages (3)
Duchenne muscular dystrophy (26)
Earnings (16720)
Editorial (7)
Employer resources (19)
Events (30847)
Executive appointments (286)
FDA (3535)
Featured Employer (14)
Frontotemporal dementia (5)
Funding (265)
Gene editing (27)
Generative AI (7)
Gene therapy (105)
GLP-1 (162)
Government (708)
Guidances (11)
Healthcare (3150)
Huntington's disease (8)
IgA nephropathy (7)
Immunology and inflammation (42)
Indications (13)
Infectious disease (824)
Inflammatory bowel disease (59)
Inflation Reduction Act (2)
Influenza (23)
Intellectual property (37)
Interviews (17)
IPO (3720)
IRA (7)
Job creations (785)
Job search strategy (193)
Kidney cancer (2)
Labor market (7)
Layoffs (84)
Legal (906)
Liver cancer (34)
Lung cancer (324)
Lymphoma (75)
Machine learning (1)
Management (5)
Manufacturing (95)
MASH (10)
Medical device (1007)
Medtech (1007)
Mergers & acquisitions (4074)
Metabolic disorders (136)
Multiple sclerosis (26)
NASH (1)
Neurodegenerative disease (21)
Neuropsychiatric disorders (4)
Neuroscience (506)
NextGen: Class of 2025 (1107)
Non-profit (658)
Northern California (976)
Now hiring (6)
Obesity (68)
Opinion (50)
Ovarian cancer (42)
Pain (21)
Pancreatic cancer (38)
Parkinson's disease (42)
Partnered (4)
Patents (64)
Patient recruitment (44)
Peanut (17)
People (18282)
Pharmaceutical (8)
Phase I (8351)
Phase II (10623)
Phase III (6675)
Pipeline (455)
Policy (29)
Postmarket research (526)
Preclinical (3547)
Press Release (51)
Prostate cancer (37)
Psychedelics (6)
Radiopharmaceuticals (82)
Rare diseases (152)
Real estate (1557)
Recruiting (10)
Regulatory (4886)
Reports (13)
Research institute (607)
Resumes & cover letters (20)
RNA editing (2)
RSV (16)
Schizophrenia (20)
Series A (44)
Series B (33)
Service/supplier (2)
Sickle cell disease (18)
Southern California (880)
Special edition (2)
Spinal muscular atrophy (38)
Sponsored (6)
Startups (1139)
State (1)
Stomach cancer (7)
Supply chain (19)
Tariffs (4)
The Weekly (10)
United States (7694)
Vaccines (162)
Venture capitalists (10)
Weight loss (30)
Women's health (6)
Worklife (2)
Date
Today (53)
Last 7 days (178)
Last 30 days (846)
Last 365 days (11462)
2025 (3226)
2024 (12093)
2023 (13232)
2022 (16355)
2021 (17026)
2020 (14083)
2019 (9388)
2018 (7386)
2017 (8306)
2016 (7749)
2015 (8882)
2014 (6522)
2013 (5248)
2012 (5494)
2011 (6089)
2010 (5678)
Location
Africa (167)
Alabama (32)
Alaska (1)
Arizona (35)
Arkansas (3)
Asia (11839)
Australia (2465)
California (2232)
Canada (647)
China (221)
Colorado (46)
Connecticut (98)
Delaware (56)
Europe (24765)
Florida (215)
Georgia (30)
Idaho (12)
Illinois (159)
India (6)
Indiana (98)
Iowa (1)
Japan (53)
Kansas (14)
Kentucky (4)
Louisiana (1)
Maine (2)
Maryland (284)
Massachusetts (1627)
Michigan (74)
Minnesota (113)
Missouri (15)
Montana (15)
Nebraska (2)
Nevada (7)
New Hampshire (6)
New Jersey (613)
New Mexico (9)
New York (584)
North Carolina (366)
North Dakota (3)
Northern California (976)
Ohio (46)
Oklahoma (5)
Oregon (5)
Pennsylvania (440)
Puerto Rico (3)
Rhode Island (10)
South America (235)
South Carolina (1)
Southern California (880)
Tennessee (16)
Texas (314)
Utah (23)
Virginia (19)
Washington D.C. (9)
Washington State (359)
Wisconsin (12)
172,923 Results for "lung biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MAIA Biotechnology Announces Poster Presentation at ESMO’s European Lung Cancer Congress 2025
March 25, 2025
·
5 min read
Lung cancer
J&J’s Lung Cancer Combo Bests AstraZeneca’s Tagrisso, Reducing Risk of Death 25%
The latest data from Johnson and Johnson’s Rybrevant and Lazcluze lung cancer combo was better than standard of care Tagrisso on overall survival. But analysts say the next step is getting a subcutaneous formula approved.
March 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Small Cell Lung Cancer Market Size to Reach USD 23.0 Billion by 2035, Impelled by Improved Early Diagnosis & Biomarker Research
Small Cell Lung Cancer Market Outlook 2025-2035:
February 17, 2025
·
9 min read
Press Releases
MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer
February 26, 2025
·
6 min read
Press Releases
Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer
March 27, 2025
·
7 min read
Press Releases
MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer
February 4, 2025
·
6 min read
Press Releases
MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients
February 27, 2025
·
4 min read
Press Releases
IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER
April 14, 2025
·
22 min read
Drug Development
Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the initiation of its ALISertib in CAncer (ALISCA-Lung1) Phase II trial (PUMA-ALI-4201; NCT06095505) of alisertib monotherapy for the treatment of patients with extensive stage small cell lung cancer.
February 13, 2024
·
4 min read
Press Releases
Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer
March 13, 2025
·
5 min read
1 of 17,293
Next
